The Klingenstein Third Generation Foundation
Scientific Advisory Board

Thomas F. Anders, M.D.

Distinguished Professor of Psychiatry and Behavioral Sciences Emeritus

UC Davis M.I.N.D. Institute

Consulting Professor of Psychiatry

Stanford University School of Medicine

Clinical Professor of Psychiatry

University of California, San Francisco

Adjunct Professor of Psychiatry

Brown University School of Medicine

Joan Asarnow, Ph.D.

Professor of Psychiatry and Biobehavioral Sciences
Director of the UCLA Youth Stress and Mood Program

William R. Beardslee, M.D.

Director, Baer Prevention Initiatives

Boston Children's Hospital and Gardner/Monks Professor of Child Psychiatry, Harvard Medical School

David A. Brent, M.D.

Academic Chief, Child & Adolescent Psychiatry

Endowed Chair in Suicide Studies

Professor of Child Psychiatry, Pediatrics & Epidemiology

University of Pittsburgh School of Medicine

Kiki Chang, M.D., Former Fellow

Associate Professor, Department of Psychiatry and Behavioral Sciences

Stanford University School of Medicine

Anne Glowinski, M.D., Former Fellow

Professor of Child and Adolescent Psychiatry

Associate Chief, Division of Child and Adolescent Psychiatry

Washington University School of Medicine

Laurence L Greenhill, M.D.

Ruane Professor of Clinical Child and Adolescent Psychiatry

New York-Presbyterian/Columbia

Alex Kolevzon, MD

Professor of Psychiatry and Pediatrics
Director, Child and Adolescent Psychiatry
Mount Sinai Health System
Clinical Director, Seaver Autism Center
Icahn School of Medicine at Mount Sinai

Jeffrey H. Newcorn, M.D. , Advisory Board Chair

Professor of Psychiatry and Pediatrics
Director, Division of ADHD and Learning Disorders Icahn School of Medicine at Mount Sinai Director, Pediatric Psychopharmacology Mount Sinai Health System


Heidi Fordi

Executive Director

American Academy of Child and Adolescent Psychiatry

Karen Wagner, M.D, Ph.D.
American Academy of Child and Adolescent Psychiatry

Emeritus Advisor

Beatrix A. Hamburg, M.D.

DeWitt Wallace Distinguished Scholar and Co-Chair Social Medicine & Public Policy Program

Weil-Cornell Medical College

In Memoriam

Donald J. Cohen, M.D. (September 5, 1940 - October 2, 2001)


Yale University's Child Study Center

Julius B. Richmond, M.D. (September 26, 1916 – July 27, 2008)

Professor of Health Policy, Department of Social Medicine

Harvard Medical School

The Foundation has a conflicts of interest policy for its Scientific Advisory Board, which is available upon request.

Dr. Thomas F. Anders

Dr. Anders is Distinguished Professor of Psychiatry and Behavioral Sciences (Emeritus) at the UC Davis M.I.N.D. Institute and the former President of the American Academy of Child and Adolescent Psychiatry (AACAP).

Dr. Anders is a graduate of Stanford University School of Medicine (1960). Following a rotating internship at Mount Sinai Hospital, NYC, and 1 year of pediatric residency at Children's Hospital Medical Center, Boston, he served for 2 years as a flight surgeon and USAF pediatrician in Tripoli Libya (1962-1964).

Dr. Anders then completed psychiatry training and psychoanalytic training at Columbia Presbyterian Medical Center, NY, followed by a two-year NIMH research fellowship and subsequent NIMH Career Development Award at Albert Einstein College of Medicine, NY. He was appointed Director of the Division of Child and Adolescent Psychiatry at SUNY/Buffalo in 1972 and then headed Divisions of Child and Adolescent Psychiatry at Stanford University (1974-1984) and Brown University (1985-1992).

Dr. Anders joined the faculty of UC Davis as Chair, Department of Psychiatry (1992-1998) and then was appointed Executive Associate Dean of the School of Medicine (1998-2002). He formally retired from the University of California in 2005. Currently, he is Adjunct Professor of Psychiatry at Brown University, developing a state-wide autism research and treatment consortium in Rhode Island, centered at Bradley Hospital. He is also a Professor of Clinical Psychiatry at UCSF.

Dr. Anders has had long standing clinical and research interests in the areas of maturation of infant sleep-wake states and pediatric sleep disorders. He is an NIH-funded investigator, currently studying sleep-wake patterns and sleep disorders in children with autism, developmental delay without autism and age-matched typically developing children.


Joan Asarnow, Ph.D.

Dr. Joan Asarnow is a Professor of Psychiatry and Biobehavioral Sciences at UCLA and Director of the UCLA Youth Stress and Mood Program, a depression and suicide prevention program with clinical, educational, and research components.  She received her PhD in clinical psychology from the University of Waterloo where she studied with Dr. Donald Meichenbaum one of the founding fathers of cognitive-behavior therapy, and completed an NIMH post-doctoral fellowship focusing on family treatments and the impact of family processes on child and adolescent development and well-being.

As President of the Society for Clinical Child & Adolescent Psychology (American Psychological Association, Division 53), she developed and led a national initiative on enhancing health and behavioral health care systems and improving care for children and families and forged collaborative work with the American Academy of Child & Adolescent Psychiatry, the American Academy of Pediatrics, and other organizations dedicated to the health and well-being of children and adolescents. 

Dr. Asarnow has led efforts to disseminate evidence-based treatments for youth suicide and suicide attempt prevention and depression.  She directs the UCLA-Duke SAMHSA-funded Center for Trauma-Informed Adolescent Suicide, Self-Harm & Substance Abuse Prevention, with co-director Dr. David Goldston.  Two programs developed by Dr. Asarnow are listed in the National Registry for Evidence-Based Programs (SAMHSA): 1) the Family Intervention for Suicide Prevention, a crisis treatment for youths after a suicidal/self-harm episode; and 2) Depression Treatment Quality Improvement, an evidence-based depression treatment program that has been integrated within primary care, mental health, and other settings. Dr. Asarnow has received grants from the National Institute of Mental Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Substance Abuse and Mental Health Services Administration, American Foundation for Suicide Prevention, and other organizations.  She currently leads a large NIMH-funded randomized controlled trial evaluating a stepped care intervention for adolescents and young adults aimed at advancing the goal of zero suicide within a large health system.

Dr. William R. Beardslee

William R. Beardslee, M.D. is the Director of the Baer Prevention Initiatives at Boston Children's Hospital and the Gardner Monks Professor of Child Psychiatry at Harvard Medical School.

Dr. Beardslee received his B.A. from Haverford College and his M.D. from Case Western Reserve University.

Dr. Beardslee has a longstanding research interest in the development of children at risk because of severe parental mental illness. He has been especially interested in the protective effects of self-understanding in enabling youngsters and adults to cope with adversity and has studied self-understanding in civil-rights workers, survivors of cancer, and children of parents with affective disorders.

He developed a preventive intervention for families facing depression, Family Talk, that received very high rankings in the National Registry of Evidence-based Programs and Practices and has been used widely in this country and abroad. This work has been adapted for use with single parent African American families, Latino families, and for use in Head Start. He directed the Boston site of a four-site study examining a cognitive-behavioral preventive intervention for youth at risk for depression which has demonstrated actual prevention of episodes of major depression at nine-month, 33 month and 75 month follow-ups. He served on three National Academy of Medicine committees recently, one dealing with the prevention of mental illness in children, youth and families, a second on parental depression, and a third on interventions for young children. He co-chairs the National Academy of Medicine's forum on promoting children's cognitive and affective and behavioral health.

Dr. Beardslee has received the Blanche F. Ittleson award of the American Psychiatric Association for outstanding published research contributing to the mental health of children, has been a Faculty Scholar of the William T. Grant foundation, and in 1999, received the Irving Philips Award for Prevention and the Catcher in the Rye Award for Advocacy for Children from the American Academy of Child and Adolescent Psychiatry. In 2003, Dr. Beardslee received the Agnes Purcell McGavin Award for Prevention of Mental Disorder in Children from the American Psychiatric Association and in 2005, the Human Rights Award of the Department of Mental Health of the Commonwealth of Massachusetts and in 2006, the Lela Rowland Prevention Award of the National Mental Health Association. He received an Honorary Doctor of Science Degree from Emory University and the Judge Baker Children's Center World of Children Award in 2011.

Dr. Beardslee is the author of over 250 articles and book chapters and of two books. He is married and has four children.

Dr. David Brent, M.D.

Dr. Brent is currently Academic Chief, Child and Adolescent Psychiatry at Western Psychiatric Institute and Clinic and Professor of Psychiatry, Pediatrics & Epidemiology, University of Pittsburgh School of Medicine and holds an endowed chair in Suicide Studies. He co-founded and now directs Services for Teens at Risk (STAR), a Commonwealth of Pennsylvania-funded program for suicide prevention, education of professionals, and the treatment of at-risk youth and their families.

Dr. Brent is a member of the Institute of Medicine and has been recognized for his research by the American Academy of Child and Adolescent Psychiatry, the American Psychiatric Association, the American Foundation for Suicide Prevention, and received the Ruane Prize for research in child psychiatry from NARSAD.

His work has focused on the identification of risk factors for adolescent depression and suicidal behavior, and on the translation of those findings into clinical interventions. Along with many other colleagues, Dr. Brent helped to establish the role of cognitive therapy as a treatment for depressed adolescents and developed guidelines for the management of treatment resistant depression. Dr. Brent and colleagues have endeavored to understand possible intermediate phenotypes for suicidal behavior and mechanisms by which suicidal behavior is transmitted from parent to child.

Dr. Kiki Chang, M.D., Former Fellow

Dr. Kiki Chang is Professor of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine, Lucille Packard Children's Hospital, Division of Child Psychiatry. He is Director of the Pediatric Bipolar Disorders Clinic and Research Program, where he specializes in pediatric psychopharmacology and treatment of depression and bipolar disorder in children and adolescents. His research includes brain imaging, genetics, immunologic markers, psychotherapy, and medication trials. He is particularly interested in studying risk factors for bipolar illness and early interventions that might prevent the disorder altogether.

Dr. Chang is also Director of the Pediatric Inflammatory Neuropsychiatric Syndrome Research Program and Co-Founder of the Stanford PANS/PANDAS Clinic at LPCH.

Dr. Chang graduated cum laude from Princeton University in 1988 and received his M.D. from the Tufts University School of Medicine in 1993. He completed his general psychiatry residency at the University of Cincinnati and his child psychiatry fellowship at Stanford University. After a postdoctoral research fellowship, Dr. Chang joined the Stanford faculty in 1999.

Dr. Chang is the recipient of the 2003 American Psychiatric Association/ AstraZeneca Young Minds in Psychiatry Award. In addition to receiving three grants from NARSAD, he was awarded a Klingenstein Third Generation Fellowship in 2000 and has since received a 5-year Career Development Award from the National Institutes of Health as well as multiple R34 and R01-level grants from the NIMH.

Dr. Chang is the author of over 90 papers and book chapters regarding bipolar disorder in children and has presented widely at national and international scientific conferences and meetings.

Started a private practice in 2017 specializing in youth and adults with mood disorders and neuropsychiatric disorders such as PANS/PANDAS.

Heidi B. Fordi, CAE

Heidi Fordi is the Executive Director of the American Academy of Child and Adolescent Psychiatry (AACAP).

AACAP represents over 8,500 child and adolescent psychiatrists. Its members are physicians with at least five years of additional training beyond medical school in general and child and adolescent psychiatry. AACAP members actively research, diagnose and treat psychiatric disorders affecting children, adolescents, and their families.

In 2008, Ms. Fordi earned the status of Certified Association Executive (CAE) from the American Society of Association Executives (ASAE). This represents rigorous training and examination on all aspects of association management.

As AACAP Executive Director, Ms. Fordi oversees a staff of 38 and a budget of $8 million.

Dr. Anne Glowinski

Dr. Glowinski is a physician scientist and educator at Washington University School of Medicine (WUSM), where she is a Professor of Child and Adolescent Psychiatry on the tenure track and the Director of Education and Training for Child and Adolescent Psychiatry. Her professional development and training occurred across multiple institutions, starting at Baylor College of Medicine where she completed medical school. She continued at the Johns Hopkins Medical Institutions, where she completed post-graduate clinical training in Psychiatry and Child and Adolescent Psychiatry, and at WUSM where she completed a T32 NIH funded research post-doctoral fellowship. At WUSM, she also earned a Master in Psychiatric Epidemiology (MPE) and received two esteemed awards/grants: a 1999 Klingenstein Third Generation Foundation (KTGF) Fellowship award for youth depression research and a 2001 NARSAD Young Investigator Award.

She was awarded a NIMH Mentored (by Dr. Heath) Clinical Scientist Development Award in 2002 to study the familial transmission of youth suicidal behavior. The high quality of Dr. Glowinski’s work has been recognized by several honors over the last few years, including, notably, the 2002 Journal of the American Academy of Child and Adolescent Psychiatry (AACAP) Award for best paper on depression or suicide, a 2004 AACAP Teaching Scholar Award and the honorable mention of the NARSAD 2005 Klerman Award for Outstanding Clinical Research Achievement by a NARSAD Young Investigator. She is one of very few child psychiatrists with substantial expertise in twin research including expertise with twin data genetic analyses.

Dr. Alex Kolevzon

Alex Kolevzon is a child and adolescent psychiatrist and a Professor of Psychiatry and Pediatrics at the Icahn School of Medicine at Mount Sinai. Dr. Kolevzon serves as the Director of Child and Adolescent Psychiatry for the Mount Sinai Health System and the Clinical Director of the Seaver Autism Center for Research and Treatment. His research interests pertain to understanding the neurobiology of autism spectrum disorder and developing novel therapeutics.

Most recently, his group has focused on studying specific genetic forms of autism, including Fragile X syndrome and Phelan-McDermid syndrome, in order to better understand the clinical presentation, develop objective outcome measure, and explore possible targets for pharmacological intervention. His research in Phelan-McDermid syndrome has led to a Rare Disease Clinical Research Network funded by the NIH and he is also the Principal Investigator on the only clinical trial in the United States of a novel therapeutic in this rare disorder. 

Dr. Kolevzon is also committed to medical student and residency education as an active teacher, mentor, and clinical supervisor. He has consistently won teaching and mentoring awards for the past 15 years and written several books designed for medical student and resident education. Since 2005, Dr. Kolevzon has led efforts to evaluate the KTGF Medical Student Training Program (MSTP) in Child and Adolescent Psychiatry and has served as Chair of the National MSTP Network.

Dr. Jeffrey H. Newcorn

Dr. Jeffrey Newcorn received his medical degree from the University of Rochester in New York (1977). He completed his general psychiatry (1980) and child and adolescent psychiatry (1982) training at Tufts-New England Medical Center, Boston. Dr. Newcorn is currently professor of psychiatry and pediatrics, and director, Division of ADHD and Learning Disorders at Icahn School of Medicine at Mount Sinai. He is also the director of Pediatric Psychopharmacology for the Mount Sinai Health System.

Dr. Newcorn is a highly regarded clinician - researcher with special expertise in the areas of ADHD, aggression, descriptive psychopathology of child and adolescent disorders, and child and adolescent psychopharmacology, whose academic work spans both clinical and translational topics. He has been a member of the steering committee of the NIMH-funded multicenter study "Multimodal Treatment of Children with ADHD (MTA) (serving as chair in 2000)." He was the principal investigator on an NIMH-funded ADHD Research Infrastructure Network devoted to understanding the neurobiology of ADHD, and has been (and currently is) the principal investigator or co-investigator on several NIMH-funded and industry-funded grants which examine the clinical presentation and neurobiological basis of ADHD and its treatment.

Dr. Newcorn is an internationally recognized educator and mentor, and an editorial board member of several leading child psychiatry/psychology, and psychopharmacology journals. He directs an active clinical trials program, and has studied many of the newer medication treatments for ADHD. He has published over 300 articles and chapters in textbooks on these and related subjects. Dr. Newcorn's most recent research focuses on the clinical and neurobiological basis of differential response to ADHD treatments, utilizing data obtained from clinical, pharmacogenetic and fMRI measures.

Dr. Newcorn has held several prominent positions in US and international organizations. He was a member of the child psychiatry working group for DSM-IV, and a consultant to the American Psychiatric Association DSM for primary care. He is a founding member of the board of directors of the American Professional Society for ADHD and Related Disorders (APSARD) (currently serving as president-elect), and chair of the advisory board of the Klingenstein Third Generation Foundation. He has had a major role in organizing scientific meetings for ADHD worldwide, have served as chair of the APSARD program committee, the scientific program committee for the World Federation of ADHD 5th (Glasgow) and 6th (Vancouver) International Congresses, and the organizing committee for the 2nd International Symposium on ADHD in Tel Aviv.

Dr. Beatrix A. Hamburg, M.D.

Beatrix A. Hamburg is DeWitt Wallace Distinguished Scholar in the Department of Psychiatry at the Weill Medical College of Cornell University and Co-Director of the Social Medicine and Public Policy Program. She is the past President of the William T. Grant Foundation. Dr. Hamburg has had an outstanding career in academic medicine as well as in public service. Her professorships were at the Stanford University School of Medicine, Harvard Medical School, and the Mount Sinai School of Medicine in their respective departments of Psychiatry. At both Stanford and Mount Sinai School of Medicine, she was also Director of the Division of Child Psychiatry. Dr. Hamburg received her B.A. from Vassar College and her M.D. from Yale University School of Medicine.

Dr. Hamburg was elected to membership in the Institute of Medicine, National Academy of Sciences. She is a Fellow of the American Association for the Advancement of Science and the Royal Society of Medicine of London. She is a member of numerous other professional societies, including the American Academy of Child and Adolescent Psychiatry, the Society for Adolescent Research, the Society for Research in Child Development, the American Public Health Association, the Society for Adolescent Medicine, and New York Academy of Medicine. She served as Expert Consultant for Children and Youth for the World Health Organization, Division of Mental Health.

Dr. Hamburg's research has been in normal adolescence, adolescent psychopathology, and endorcrine-behavior interactions. She is most noted for her pioneering work on peer counseling, studies of diabetic children and adolescents, studies of the health and mental health status of minority populations, her insight into recognizing early adolescence as a distinctive and critical developmental period and her clinical research on school-based programs for conflict resolution and violence prevention in the schools. She published a book on "Violence in American Schools." Most recently, a book, "Learning to Live Together: Preventing Hatred and Violence in Child and Adolescent Development," jointly authored with Dr. David Hamburg, was published April, 2004 by Oxford University Press.

Dr. Hamburg has served on the boards of the Bush Foundation, the Revson foundation, the Greenwall Foundation, and the New World Foundation. She has been a member of the Committee on Successful Adolescence of the John D. and Catherine T. MacArthur Foundation and the Carnegie Council on Adolescence. In New York State, Dr. Hamburg served on the Public Health Council, the Governor's Task Force on Life and Law, and the New York State Council on Graduate Medical Education. Currently, she serves as a member of the New York City Board of Health and Mental Hygiene and the Klingenstein Third Generation Foundation Advisory Board.

Dr. Hamburg has received many honors and awards, including the NARSAD Lifetime Achievement Award, the Brownell Prize, T. Ross Gallagher Award from the Society of Adolescent Medicine, the National Institute of Mental Health (NIMH) Award for Outstanding Achievement, and the Society for Research in Child Development Research Award for distinguished contributions to public policy for children, the David Rogers Medal for Health Policy. Dr. Hamburg is the recipient of an honorary degree from Northwestern University.

Dr. Julius B. Richmond, M.D.

Dr. Julius B. Richmond was the John D. MacArthur Professor of Health Policy, Emeritus at Harvard University. From 1983 to 1988 he was Director of the Division of Health Policy Research and Education at Harvard University. He served as Professor of Child Psychiatry and Human Development at the Harvard Medical School as well as Chairman of Psychiatry at Children’s Hospital and Director of the Judge Baker Children’s Center from 1971-77.

From 1977 to 1981 Dr. Richmond served as Surgeon-General and Assistant Secretary of the Department of Health and Human Services.  During this time he had responsibility for administering all of the agencies of the US Public Health Service.  In 1979 he issued the report, Healthy People:  The Surgeon-General's Report on Health Promotion and Disease Prevention.  This report for the first time established quantitative health goals for the nation for the next decade–a process which has been institutionalized by the US Public Health Service through its recent report, Healthy People 2010:  National Health Promotion and Disease Prevention Objectives.

Dr. Richmond was trained in pediatrics and child development and pioneered in introducing psychosocial development into pediatric education, research and services.  His collaborative work with Dr. Bettye Caldwell on the development of young children growing up in poverty led to his appointment in 1965 as the first director of the national Head Start program. He also served as assistant director for health affairs of the OEO and directed the Community Health Centers program.  He has received numerous awards and honorary degrees.

He has co-authored, with Professor Rashi Fein, a book, The Health Care Mess: How We Got Into It And What It Will Take To Get Out (Harvard University Press 2005). It is a history of medical care and education in the United States and presents recommendations for national health policy.

Advisors, please enter the grants system here